CAS: 5511-98-8; α-Acetyl Digoxin

该化合物是一种来自二恶英的心脏球体,通常用于治疗心脏状况,如甲状腺纤维化和心脏衰竭.该化合物的特点是能够抑制纳+/K+甲酸酯酶,导致细胞内钙浓度增加和心脏接触性增强. -乙酰二恶英的分子配方反映了其复杂结构,包括一种类固核和糖味.它通常以药物形式进行施用,其药理学学涉及吸收,分配,代谢和排泄过程,对于其治疗效果至关重要.该化合物表现出相对较高的生物利用率和长期的半衰期,允许在临床环境中每天一次服用.此外,乙酰二恶英可能有一个较窄的治疗窗口,需要仔细监测血清水平以避免毒性.其使用在某些条件下是反常态的,它可能与各种药物发生相互作用,突出全面了解其药理学概况的重要性.

结构式图片

上下游产品

lanatoside C acetyl chloride digoxin digoxin digoxigenin beta-Acetyldigoxin

合成工艺路线路线简述

    📜毛花苷c 反应生成 α-乙酰基地高辛
    参考文献:Fuska,Jan;Proksa,Bohumil;Khandlova,Alzbeta
    标题:Fuska,Jan;Proksa,Bohumil;Khandlova,Alzbeta

    海关参考信息

    专利信息


    专利号:WO-0112817-A1
    优先权日:1999-08-12
    标题:Evolution and use of enzymes for combinathorial and medicinal chemistry
    发明人:KREBBER CLAUS; DAVIS S CHRISTOPHER; DELCARDAYRE STEPHEN; SELIFONOV SERGEY A; HOWARD RUSSELL
    权利人:MAXYGEN INC; LIU LU; KREBBER CLAUS; DAVIS S CHRISTOPHER; DELCARDAYRE STEPHEN; SELIFONOV SERGEY A; HOWARD RUSSELL
    摘要:This invention provides libraries of recombinant derivatizing enzymes that are useful for biocatalytic synthesis of derivatives oforganic molecules, including lead compounds for pharmaceutical use. The recombinant derivatizing enzymes catalyze reactions such as modification or replacement of functional groups on the organicmolecules, or addition of chemical moieties onto preexisting functional groups. The use of recombinant enzyme libraries enables one to obtain enzymes that catalyze the formation of organic molecule derivatives that could not otherwise be made using only naturally occurring enzymes.

    专利号:US-6699676-B1
    优先权日:1999-06-03
    标题:Uses of ouabain and ouabain-like molecules in apoptosis related pathologies
    发明人:ORLOV SERGEI N; HAMET PAVEL; TREMBLAY JOHANNE
    权利人:CORP DU CT DE RECH DU CT HOSPI
    摘要:Longterm elevation of the intracellular Na + /K + ratio inhibits macromolecule synthesis and proliferation in the majority of cell types studied so far, including vascular smooth muscle cells (VSMC). We report here that inhibition of the Na + ,K + pump in VSMC by ouabain or 1 hour preincubation in K + -depleted medium attenuated apoptosis triggered by serum withdrawal, staurosporine or okadaic acid. In the absence of ouabain, both DNA degradation and caspase-3 activation in VSMC undergoing apoptosis were insensitive to modification of the extracellular Na + /K + ratio as well as to hyperosmotic cell shrinkage. In contrast, protection of VSMC from apoptosis by ouabain was abolished under equimolar substitution of Na + o with K + o , showing that the anti apoptotic action of Na + ,K + pump inhibition was caused by inversion of the intracellular Na + /K + ratio. Unlike VSMC, the same level of increment of the [Na + ] i /[K + ] i ratio caused by 2 hours preincubation of Jurkat cells with ouabain did not affect chromatin cleavage and caspase-3 activity triggered by treatment with Fas ligand, staurosporine or hyperosmotic shrinkage. Thus, our results show for the first time that similarly to cell proliferation, maintenance of a physiologically low intracellular Na + /K + ratio is required for progression of VSMC apoptosis.

    专利号:RU-2151143-C1
    优先权日:1993-11-15
    标题:Substituted 5-membered heterocycles, method of their synthesis, pharmaceutical composition

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Pauli-Magnus C, Mürdter T, Godel A, Mettang T, Eichelbaum M, Klotz U, Fromm MF. P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin. Naunyn Schmiedebergs Arch Pharmacol. 2001 Mar;363(3):337-43. doi: 10.1007/s00347-007-1630-x. German. German. Russian. German. Russian. German. German. German.

    合成参考文献


    摘要:Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology., 70(39), 1974 []
    摘要:Arzneimittel-Forschung. Drug Research., 22(1854), 1972 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知